Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Rehavi

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Life Sciences|June 12, 2012
Anxiolytic effects of a novel herbal treatment in mice models of anxietyRavid Doron, Dafna Lotan, Anat Rak-Rabl, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 6, 2005
Reduced platelet vesicular monoamine transporter density in smoking schizophrenia patientsKarin Schwartz, Iulian Iancu, Rafael Stryjer, et al.
Pharmacogenomics|February 22, 2011
Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarkerAyelet Morag, Metsada Pasmanik-Chor, Varda Oron-Karni, et al.
Translational Psychiatry|May 5, 2021
Moderation of the transgenerational transference of antenatal stress-induced anxietyOr Burstein, Noam Simon, Yaarit Simchon-Tenenbaum, et al.
Journal of Molecular Neuroscience : MN|July 11, 2019
Cerebral MAO Activity Is Not Altered by a Novel Herbal Antidepressant TreatmentRavid Doron, Ziv Versano, Or Burstein, et al.
Psychiatry Research|September 1, 2005
Platelet vesicular monoamine transporter density in untreated patients diagnosed with social phobiaNeil Laufer, Michal Zucker, Haggai Hermesh, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 9, 2007
Reduced platelet vesicular monoamine transporter density in Tourette's syndrome pediatric male patientsDavid H Ben-Dor, Sharon Zimmerman, Jonathan Sever, et al.
Plos One|April 3, 2014
Escitalopram or novel herbal mixture treatments during or following exposure to stress reduce anxiety-like behavior through corticosterone and BDNF modificationsRavid Doron, Dafna Lotan, Ziv Versano, et al.
Journal of Child and Adolescent Psychopharmacology|August 20, 2011
Platelet vesicular monoamine transporter 2 density in the disruptive behavior disordersGil Zalsman, Dorit Aslanov-Farbstein, Moshe Rehavi, et al.
Journal of Molecular Neuroscience : MN|May 9, 2018
GABA<sub>A</sub> Receptor Density Is Not Altered by a Novel Herbal Anxiolytic TreatmentRavid Doron, Avital Sever, Assaf Handelsman, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Life Sciences|June 12, 2012
Anxiolytic effects of a novel herbal treatment in mice models of anxietyRavid Doron, Dafna Lotan, Anat Rak-Rabl, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 6, 2005
Reduced platelet vesicular monoamine transporter density in smoking schizophrenia patientsKarin Schwartz, Iulian Iancu, Rafael Stryjer, et al.
Pharmacogenomics|February 22, 2011
Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarkerAyelet Morag, Metsada Pasmanik-Chor, Varda Oron-Karni, et al.
Translational Psychiatry|May 5, 2021
Moderation of the transgenerational transference of antenatal stress-induced anxietyOr Burstein, Noam Simon, Yaarit Simchon-Tenenbaum, et al.
Journal of Molecular Neuroscience : MN|July 11, 2019
Cerebral MAO Activity Is Not Altered by a Novel Herbal Antidepressant TreatmentRavid Doron, Ziv Versano, Or Burstein, et al.
Psychiatry Research|September 1, 2005
Platelet vesicular monoamine transporter density in untreated patients diagnosed with social phobiaNeil Laufer, Michal Zucker, Haggai Hermesh, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 9, 2007
Reduced platelet vesicular monoamine transporter density in Tourette's syndrome pediatric male patientsDavid H Ben-Dor, Sharon Zimmerman, Jonathan Sever, et al.
Plos One|April 3, 2014
Escitalopram or novel herbal mixture treatments during or following exposure to stress reduce anxiety-like behavior through corticosterone and BDNF modificationsRavid Doron, Dafna Lotan, Ziv Versano, et al.
Journal of Child and Adolescent Psychopharmacology|August 20, 2011
Platelet vesicular monoamine transporter 2 density in the disruptive behavior disordersGil Zalsman, Dorit Aslanov-Farbstein, Moshe Rehavi, et al.
Journal of Molecular Neuroscience : MN|May 9, 2018
GABA<sub>A</sub> Receptor Density Is Not Altered by a Novel Herbal Anxiolytic TreatmentRavid Doron, Avital Sever, Assaf Handelsman, et al.
Pageof 5